International Clinical Trial: An open-label, multicenter, exploratory Phase II clinical study of the efficacy and safety of TR115 in patients with advanced solid tumors with ARID1A mutations

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132021) titled 'An open-label, multicenter, exploratory Phase II clinical study of the efficacy and safety of TR115 in patients with advanced solid tumors with ARID1A mutations' on Sept. 9.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Fudan University Shanghai Cancer Center

Condition: Advanced Solid Tumors

Intervention: Un-grouped, Queue 1: Ovarian, fallopian tube or peritoneal clear cell carcinoma :Oral TR115 Tablets Queue 2: Endometrial cancer:Oral TR115 Tablets

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-09-30

Target Sample Size: Un-grouped, Queue 1: ...